Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06427096
Other study ID # HFP2024
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 23, 2024
Est. completion date August 2025

Study information

Verified date June 2024
Source Heart Health Research Center
Contact Yanna Song
Phone +86 17839372777
Email songyanna@RRH.onaliyun.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a 1:1 parallel design, multi-center, cluster-randomized control trial. A total of 80 villages in Ruyang County, Henan Province, China, will be randomly assigned to the intervention group or control group. At least 100 participants from 30-50 families in each village will be included in this study. The intervention group will engage in a variety of strategies, including adopting a low-sodium diet, managing weight, participating in physical exercise, monitoring blood pressure, and undergoing antihypertensive treatment. These efforts will be led by healthy family instructors from the community. The control group will receive usual care. The primary endpoint of this study is the change of systolic blood pressure from baseline to 6 months, reported as the difference between intervention and control group.


Description:

This cluster-randomized control trial aims to randomly allocate 80 villages in Ruyan County to either receive a multifaceted intervention led by family healthy instructors or continue with usual care. Each village will recruit around 100 individuals aged 40-80 years, with or without hypertension. In intervention villages, a blood pressure management team, headed by healthy family instructors and family leaders, will implement various strategies including promoting a low-sodium diet, weight management, physical exercise, blood pressure monitoring, and administering antihypertensive treatment. The intervention will span 6 months, followed by another 6-month follow-up period. The primary hypothesis posits that the mean systolic blood pressure change from baseline to 6 months will be higher in the intervention group compared to the control group. The objective of this "Health Family Program" is to evaluate the efficacy of a non-healthcare provider-led multifaceted intervention in enhancing healthy lifestyles and managing blood pressure among rural residents, regardless of their hypertension status, in China.


Recruitment information / eligibility

Status Recruiting
Enrollment 8000
Est. completion date August 2025
Est. primary completion date February 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years to 80 Years
Eligibility 1. Village screening: The suitable villages were initially screened according to the statistical information of the number of villages and households in Ruyang County. 2. Inclusion and Exclusion Criteria for the Family Inclusion Criteria: 1. At least 2 participants between the age of 40-80 years meet the inclusion and exclusion criteria of family members and willing to participate in this study; 2. At least one family member can use the smartphone to upload BP values. Exclusion Criteria: 1. Any family member participated in the other hypertension-related programs; 2. Inappropriate for the study decided by the healthy family instructor. 3.Inclusion and Exclusion Criteria for the Family Member Inclusion Criteria: 1. 40-80 years old, regardless of BP level and antihypertensive treatment; 2. No travel plan for more than 1 month during the study period; 3. Written or fingerprinted informed consent form. Exclusion Criteria: 1. Significant cognitive dysfunction; 2. With advanced tumor, dialysis, or other serious diseases; 3. Lying in bed for a long time or unable to take care of themselves; 4. Diagnosed of secondary hypertension; 5. Having birth plans in the next six months, pregnant or lactating women; 6. Other ineligible circumstances judged by the investigators.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Multifaceted intervention
The multifaceted interventions is comprised of the following components: To establish a BP management team led by healthy family instructor. The team members also include family leaders and village doctors. To conduct multifaceted intervention, which includes low-sodium diet, weight management, physical exercise, BP monitoring and antihypertensive treatment.

Locations

Country Name City State
China Ruyang County People's Hospital Luoyang Henan

Sponsors (1)

Lead Sponsor Collaborator
Heart Health Research Center

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary The changes of systolic blood pressure from baseline to 6 months The systolic blood pressure changes from baseline to 6 months for all villagers, reported as the difference between intervention and control group. 6 months
Secondary The changes of systolic blood pressure from baseline to 12 months The systolic blood pressure changes from baseline to 12 months, reported as the difference between intervention and control group. 12 months
Secondary The changes of diastolic blood pressure from baseline to 6 months The diastolic blood pressure changes from baseline to 6 months, reported as the difference between intervention and control group. 6 months
Secondary The percentage of blood pressure =130/80mmHg The percentage of blood pressure =130/80mmHg at 6 months, reported as the difference between intervention and control group. 6 months
Secondary The percentage of hypertensive participants receiving antihypertensive treatment The percentage of hypertensive participants receiving antihypertensive treatment at 6 months, reported as the difference between intervention and control group. 6 months
Secondary The percentage of hypertensive participants achieving blood pressure goal The percentage of hypertensive participants who achieved blood pressure goal <130/80mmHg at 6 months, reported as the difference between intervention and control group. 6 months
Secondary The weight changes The weight changes from baseline to 6 months, reported as the difference between intervention and control group. 6 months
Secondary The major cardiovascular events The incidence of major cardiovascular events including nonfatal stroke, nonfatal myocardial infarction, hospitalization for heart failure, and cardiovascular death within 6 months, reported as the difference between intervention and control group. 6 months
See also
  Status Clinical Trial Phase
Completed NCT03255187 - Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution N/A
Completed NCT05997303 - Continuous Norepinephrine Administration and Blood Pressure Stability During Anesthetic Induction N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT03918486 - Caretaker vs. Routine Blood Pressure Sphygmomanometer
Completed NCT03410342 - The Effects of Types of Fruits and Vegetables on Vascular Function N/A
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT04087070 - Blood Pressure Estimation Using Noninvasive Biosignals During Pediatric Anesthesia
Completed NCT03294928 - Arterial Waveform Analysis Applying Different Positive End-Expiratory Pressure (PEEP) Levels in Healthy Volunteers N/A
Completed NCT03859934 - Metabolic Effects of Melatonin Treatment Phase 1
Completed NCT03997461 - Comparison of Arterial Tonometry Sensor With Standard Oscillometric Blood Pressure Monitoring Device N/A
Completed NCT03290716 - Diet, ExerCIse and carDiovascular hEalth (DECIDE) - Salt Reduction Strategies for the Elderly in Nursing Homes in China N/A
Recruiting NCT05196048 - Blood Pressure Sensor of Watch-type Device With ECG Technology
Recruiting NCT06460233 - Blood Pressure Changes After Bariatric Surgery
Terminated NCT03325933 - Resistance Training and Cardiometabolic Health N/A
Not yet recruiting NCT06405880 - Pharmacist Case Finding and Intervention for Vascular Prevention Trial N/A
Completed NCT02924454 - Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol. Phase 4
Completed NCT02451059 - Reducing Socioeconomic Disparities in Health at Pediatric Visits N/A
Active, not recruiting NCT02670967 - Effects of Soluble Fiber on Blood Pressure: A Meta-analysis of Randomly-controlled Trials N/A
Completed NCT02239744 - Intervention Study on the Health Impact of Air Filters in Chinese Adults N/A
Completed NCT02271633 - Nitrate Supplementation; Source Phase 4